$0.0610
0.001001.67%
At close: -
$0.0625
0.001502.46%
After Hours: 4:22 PM EDT
Comments
Loading...
CERo Therapeutics Hldgs (CERO) Forecast
NewsEarningsCERo Therapeutics Hldgs (CERO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCERo Therapeutics Hldgs (NASDAQ:CERO) Stock Quotes, Forecast and News Summary
CERo Therapeutics Hldgs Stock (NASDAQ: CERO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy CERo Therapeutics Hldgs (CERO) stock?
You can purchase shares of CERo Therapeutics Hldgs (NASDAQ:CERO) through any online brokerage.
Who are CERo Therapeutics Hldgs (CERO) competitors?
Other companies in CERo Therapeutics Hldgs’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Vincerx Pharma (NASDAQ:VINC), Immuron (NASDAQ:IMRN), Acurx Pharmaceuticals (NASDAQ:ACXP) and Imunon (NASDAQ:IMNN).
What is the forecast, or price target, for CERo Therapeutics Hldgs (CERO) stock?
There is no analysis for CERo Therapeutics Hldgs to provide a consensus price target.
What is the current price for CERo Therapeutics Hldgs (CERO)?
The stock price for CERo Therapeutics Hldgs (NASDAQ: CERO) is $0.0625 last updated January 2, 2025 at 4:22 PM EST.
Does CERo Therapeutics Hldgs (CERO) pay a dividend?
There are no upcoming dividends for CERo Therapeutics Hldgs.
When is CERo Therapeutics Hldgs (NASDAQ:CERO) reporting earnings?
CERo Therapeutics Hldgs’s Q4 earnings are confirmed for Thursday, February 20, 2025.
Is CERo Therapeutics Hldgs (CERO) going to split?
There is no upcoming split for CERo Therapeutics Hldgs.
What sector and industry does CERo Therapeutics Hldgs (CERO) operate in?
CERo Therapeutics Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.